Crossmark

[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study

Crossref DOI link: https://doi.org/10.1007/s00259-025-07299-8

Published Online: 2025-05-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Quattrini, Giulia

Gatti, Elena

Peretti, Débora Elisa

Aiello, Marco

Chevalier, Claire

Lathuiliere, Aurelien

Park, Rahel

Pievani, Michela

Salvatore, Marco

Scheffler, Max

Cattaneo, Annamaria

Frisoni, Giovanni B.

Garibotto, Valentina

Marizzoni, Moira
Funding

Funding for this research was provided by:

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_195607)

Ministero della Salute (Ministero della Salute)
License Information

Text and Data Mining valid from 2025-05-02

Version of Record valid from 2025-05-02
More Information

Article History

Received: 12 November 2024

Accepted: 17 April 2025

First Online: 2 May 2025

Declarations

:

: The gMAD/COSCODE study was approved by the competent ethics committee (Commission cantonale d’éthique de la recherche [CCER]; reference No. CCER_2016 − 01346, CCER_2020_00403) and was conducted in accordance with the first revision of the Declaration of Helsinki from 1975.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below